Answer
Although no interaction studies have been performed, cytochrome P450-mediated interactions are unlikely with nirsevimab because monoclonal antibodies do not directly affect these enzymes, and indirect effects are unlikely because nirsevimab targets an exogenous virus.
Sources for this answer
- Beyfortus 100 mg solution for injection in pre filled syringeSANOFI · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked